Presentation TCT 2012 Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice? Presenter: Rajesh Dave October 25, 2012
Presentation TCT 2012 Initiating a Renal Denervation Program Presenter: George Dangas October 25, 2012
Presentation TCT 2012 Genetic Testing for 9p21: The Case for Health Care Insurance Reimbursement Presenter: H. Robert Superko October 25, 2012
Presentation TCT 2012 Introduction, Session Outline, and Goals Presenter: Anthony Gershlick October 25, 2012
Presentation TCT 2012 Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI! Presenter: Roxana Mehran October 25, 2012
Presentation TCT 2012 Managing a Peripheral Coronary Perforation Presenter: Koen Teeuwen October 25, 2012
Presentation TCT 2012 Debate: No to Routine Thrombectomy in STEMI: Still Yet to Be Demonstrated! Presenter: Sanjit Jolly October 25, 2012
Presentation TCT 2012 Session and Participant Introduction(3) Presenter: Mark de Belder October 25, 2012
Presentation TCT 2012 Case Presentation with Discussion(4) Presenter: Thomas Stuckey October 25, 2012
Presentation TCT 2012 Final Judicial Sentence and Take-home Messages(2) Presenter: Martyn Thomas October 25, 2012